Wednesday, May 3, 2023

Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease

Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.

from NYT > Top Stories https://ift.tt/u0mKaXS
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

‘We Are Coming From Hell’: A Ukrainian City’s Evacuees Tell Survival Stories

Safely out of Oleshky after enduring years in the combat zone and a harrowing 24-hour journey, weary civilians reunited with family and frie...